XML 54 R100.htm IDEA: XBRL DOCUMENT v3.20.1
13) Stock Compensation Plans: Schedule of Activity of Stock Option Plans (Tables)
12 Months Ended
Dec. 31, 2019
Tables/Schedules  
Schedule of Activity of Stock Option Plans

 

 

 

Number ofClass A Shares

 

Weighted Average Exercise Price

 

Number ofClass C Shares

 

Weighted Average Exercise Price

Outstanding at January 1, 2018

 

     880,426

 

$    4.35

 

     523,603

 

$    5.24

Adjustment for the effect of stock dividends

 

      48,168

 

 

 

      27,491

 

 

Granted

 

     142,000

 

 

 

      90,000

 

 

Exercised

 

     (42,211)

 

 

 

               -

 

 

Cancelled

 

     (17,109)

 

 

 

     (63,814)

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2018

 

  1,011,274

 

$    4.49

 

     577,280

 

$    5.15

Adjustment for the effect of stock dividends

 

      51,018

 

 

 

      28,295

 

 

Granted

 

      81,000

 

 

 

     180,000

 

 

Exercised

 

     (45,834)

 

 

 

   (191,443)

 

 

Cancelled

 

     (11,405)

 

 

 

               -

 

 

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2019

 

  1,086,053

 

$    4.41

 

     594,132

 

$    5.36

 

 

 

 

 

 

 

 

 

Exercisable at end of year

 

 

  1,002,603

 

$    4.34

 

     405,132

 

$    5.40

 

 

 

 

 

 

 

 

 

Available options for future grant

 

     205,664

 

 

 

               -

 

 

 

 

 

 

 

 

 

 

 

Weighted average contractual term of options

 

 

 

 

 

 

 

 

outstanding at December 31, 2019

 

5.62 years

 

 

 

5.82 years

 

 

 

 

 

 

 

 

 

 

 

Weighted average contractual term of options

 

 

 

 

 

 

 

 

exercisable at December 31, 2019

 

5.26 years

 

 

 

4.54 years

 

 

 

 

 

 

 

 

 

 

 

Aggregated intrinsic value of options outstanding

 

 

 

 

 

 

 

 

at December 31, 2019 (1)

 

$1,291,602

 

 

 

$2,177,223

 

 

 

 

 

 

 

 

 

 

 

Aggregated intrinsic value of options exercisable

 

 

 

 

 

 

 

 

at December 31, 2019 (1)

 

$1,259,786

 

 

 

$159,028

 

 

                   

 

 

 

 

 

 

 

 

(1) The Company used a stock price of $5.57 as of December 31, 2019 to derive intrinsic value.